Upstream Stimulatory Factor Represses the Induction of Carnitine Palmitoyltransferase-Iβ Expression by PGC-1*

Transcriptional regulation of carnitine palmitoyltransferase-1β (CPT-1β) is coordinated with contractile gene expression through cardiac-enriched transcription factors, GATA4 and SRF. Metabolic modulation of CPT-1β promoter activity has been described with the stimulation of gene expression by oleate that is mediated through the peroxisome proliferator-activated receptor (PPAR) pathway. The coactivator, peroxisomal proliferator-activated receptor γ coactivator (PGC-1), enhances gene expression through interactions with nuclear hormone receptors and the myocyte enhancer factor 2 (MEF2) family. PGC-1 and MEF2A synergistically activateCPT-1β promoter activity. This stimulation is enhanced by mutation of the E-box sequences that flank the MEF2A binding site. These elements bind the upstream stimulatory factors (USF1 and USF2), which activate transcription in CV-1 fibroblasts. However, overexpression of the USF proteins in myocytes depresses CPT-1β activity and significantly reduces MEF2A and PGC-1 synergy. Co-immunoprecipitation studies demonstrate that PGC-1 and USF2 proteins can physically interact. Our studies demonstrate that PGC-1 stimulatesCPT-1β gene expression through MEF2A. USF proteins have a novel role in repressing the expression of theCPT-1β gene and modulating the induction by the coactivator, PGC−1.

[1]  L. Kedes,et al.  The myogenic regulatory circuit that controls cardiac/slow twitch troponin C gene transcription in skeletal muscle involves E-box, MEF-2, and MEF-3 motifs. , 1999, Gene expression.

[2]  R. Schwartz,et al.  GATA-4 and Serum Response Factor Regulate Transcription of the Muscle-specific Carnitine Palmitoyltransferase I β in Rat Heart* , 2001, The Journal of Biological Chemistry.

[3]  R. Schwartz,et al.  The avian cardiac alpha-actin promoter is regulated through a pair of complex elements composed of E boxes and serum response elements that bind both positive- and negative-acting factors. , 1994, The Journal of biological chemistry.

[4]  J. Piatigorsky,et al.  Regulation of the murine alpha B-crystallin/small heat shock protein gene in cardiac muscle , 1995, Molecular and cellular biology.

[5]  W. Schaffner,et al.  Rapid test for in vivo stability and DNA binding of mutated octamer binding proteins with 'mini-extracts' prepared from transfected cells. , 1989, Nucleic acids research.

[6]  A. Strosberg,et al.  Peroxisome Proliferator-activated Receptor (PPAR) γ Coactivator-1 Recruitment Regulates PPAR Subtype Specificity* , 2002, The Journal of Biological Chemistry.

[7]  K. M. Popov,et al.  Mechanism responsible for inactivation of skeletal muscle pyruvate dehydrogenase complex in starvation and diabetes. , 1999, Diabetes.

[8]  D. Kelly,et al.  p38 Mitogen-activated Protein Kinase Activates Peroxisome Proliferator-activated Receptor α , 2001, The Journal of Biological Chemistry.

[9]  A. Samarel,et al.  Identification of a Contractile-responsive Element in the Cardiac -Myosin Heavy Chain Gene (*) , 1996, The Journal of Biological Chemistry.

[10]  E. Park,et al.  Differential Regulation of Carnitine Palmitoyltransferase-I Gene Isoforms (CPT-I α and CPT-Iβ ) in the Rat Heart , 2001 .

[11]  D. Kelly,et al.  Transcriptional Activation Of Energy Metabolic Switches In The Developing And Hypertrophied Heart , 2002, Clinical and experimental pharmacology & physiology.

[12]  C. Dang,et al.  The basic helix-loop-helix protein upstream stimulating factor regulates the cardiac ventricular myosin light-chain 2 gene via independent cis regulatory elements , 1994, Molecular and cellular biology.

[13]  P. Puigserver,et al.  A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis , 1998, Cell.

[14]  J. Saffitz,et al.  Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. , 2000, The Journal of clinical investigation.

[15]  Z. Khuchua,et al.  Oxidative Myocytes of Heart and Skeletal Muscle Express Abundant Sarcomeric Mitochondrial Creatine Kinase , 1999, The Histochemical Journal.

[16]  P. Puigserver,et al.  Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  H. Haugen,et al.  E-box sites and a proximal regulatory region of the muscle creatine kinase gene differentially regulate expression in diverse skeletal muscles and cardiac muscle of transgenic mice , 1996, Molecular and cellular biology.

[18]  C. Liew,et al.  Factors involved in cardiogenesis and the regulation of cardiac-specific gene expression. , 1996, Circulation research.

[19]  M. Sawadogo,et al.  Functional domains of the transcription factor USF2: atypical nuclear localization signals and context-dependent transcriptional activation domains , 1996, Molecular and cellular biology.

[20]  J. McGarry,et al.  The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. , 1997, European journal of biochemistry.

[21]  Á. Kenessey,et al.  Role of USF1 phosphorylation on cardiac α-myosin heavy chain promoter activity , 2002 .

[22]  R. Roeder,et al.  Interaction of a gene-specific transcription factor with the adenovirus major late promoter upstream of the TATA box region , 1985, Cell.

[23]  N. Lenka,et al.  Structural organization and transcription regulation of nuclear genes encoding the mammalian cytochrome c oxidase complex. , 1998, Progress in nucleic acid research and molecular biology.

[24]  Guillaume Adelmant,et al.  Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1 , 2001, Nature.

[25]  Z. Khuchua,et al.  Elements Regulating Cardiomyocyte Expression of the Human Sarcomeric Mitochondrial Creatine Kinase Gene in Transgenic Mice* , 1997, The Journal of Biological Chemistry.

[26]  C. Vinson,et al.  Cell-Type-Dependent Activity of the Ubiquitous Transcription Factor USF in Cellular Proliferation and Transcriptional Activation , 1999, Molecular and Cellular Biology.

[27]  F. Hegardt,et al.  Control of Human Muscle-type Carnitine Palmitoyltransferase I Gene Transcription by Peroxisome Proliferator-activated Receptor* , 1998, The Journal of Biological Chemistry.

[28]  P. Puigserver,et al.  Modulation of Estrogen Receptor-α Transcriptional Activity by the Coactivator PGC-1* , 2000, The Journal of Biological Chemistry.

[29]  J. Molkentin,et al.  Alpha-myosin heavy chain gene regulation: delineation and characterization of the cardiac muscle-specific enhancer and muscle-specific promoter. , 1996, Journal of molecular and cellular cardiology.

[30]  W. Chin,et al.  Requirement of Helix 1 and the AF-2 Domain of the Thyroid Hormone Receptor for Coactivation by PGC-1* , 2002, The Journal of Biological Chemistry.

[31]  V. Mootha,et al.  Mechanisms Controlling Mitochondrial Biogenesis and Respiration through the Thermogenic Coactivator PGC-1 , 1999, Cell.

[32]  R. Reneman,et al.  Long-chain fatty acid-induced changes in gene expression in neonatal cardiac myocytes. , 2000, Journal of lipid research.

[33]  K. Yutzey,et al.  Different E-box regulatory sequences are functionally distinct when placed within the context of the troponin I enhancer. , 1992, Nucleic acids research.

[34]  A. Kralli,et al.  PGC-1, a versatile coactivator , 2001, Trends in Endocrinology & Metabolism.

[35]  I. Chung,et al.  Cell type‐dependent regulation of human DNA topoisomerase IIIα gene expression by upstream stimulatory factor 2 , 2001, FEBS letters.

[36]  L. Buja,et al.  Genomic DNA sequence, promoter expression, and chromosomal mapping of rat muscle carnitine palmitoyltransferase I. , 1998, Genomics.

[37]  D. Kelly,et al.  Fatty Acids Activate Transcription of the Muscle Carnitine Palmitoyltransferase I Gene in Cardiac Myocytes via the Peroxisome Proliferator-activated Receptor α* , 1998, The Journal of Biological Chemistry.

[38]  Lawrence Buja,et al.  Change in Expression of Heart Carnitine Palmitoyltransferase I Isoforms with Electrical Stimulation of Cultured Rat Neonatal Cardiac Myocytes (*) , 1996, The Journal of Biological Chemistry.

[39]  Jiandie D. Lin,et al.  Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARgamma coactivator-1. , 2001, Molecular cell.

[40]  M. Vasseur-Cognet,et al.  Glucose Regulation of Gene Transcription* , 2000, The Journal of Biological Chemistry.

[41]  D. Kelly,et al.  Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth. , 2000, The Journal of clinical investigation.

[42]  T. Maity,et al.  Ubiquitous expression of the 43- and 44-kDa forms of transcription factor USF in mammalian cells. , 1994, Nucleic acids research.

[43]  G. Cheng,et al.  The Role of GATA, CArG, E-box, and a Novel Element in the Regulation of Cardiac Expression of the Na+-Ca2+ Exchanger Gene* , 1999, The Journal of Biological Chemistry.

[44]  Rick B. Vega,et al.  The Coactivator PGC-1 Cooperates with Peroxisome Proliferator-Activated Receptor α in Transcriptional Control of Nuclear Genes Encoding Mitochondrial Fatty Acid Oxidation Enzymes , 2000, Molecular and Cellular Biology.

[45]  D. Kressler,et al.  Regulation of the transcriptional coactivator PGC-1 via MAPK-sensitive interaction with a repressor , 2001, Proceedings of the National Academy of Sciences of the United States of America.